Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML

Oncogene

Volumn 21, Issue 56 REV. ISS. 7, 2002, Pages 8541-8546

  Druker, Brian J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Bcr Abl; CML; Inhibitor; STI571; Tyrosine kinase

Indexed keywords

CYTARABINE; IMATINIB; INTERFERON; PROTEIN TYROSINE KINASE INHIBITOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW SUPPRESSION; CANCER RESISTANCE; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; DEVELOPMENTAL DISORDER; DOSE RESPONSE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG RESISTANCE; DRUG TOLERABILITY; EDEMA; HUMAN; LYMPHOCYTOPENIA; MUSCLE CRAMP; NAUSEA; NEUROLOGIC DISEASE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; RASH;

EID: 0037049772     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206081     Document Type: Article

References (59)

1. Anafi M, Gazit A, Zehavi A, Ben-Neriah Y and Levitzki A. (1993). Blood, 82, 3524-3529.
2. Beran M, Cao X, Estrov Z, Jeha S, Jin G, O'Brien S, Talpaz M, Arlinghaus RB, Lydon NB and Kantarjian H. (1998). Clin. Cancer Res., 4, 1661-1672.
3. Boutin JA. (1994). Int. J. Biochem., 26, 1203-1226.
4. Branford S, Rudzki Z, Walsh S, Grigg A, Arthur C, Taylor K, Herrmann R, Lynch KP and Hughes TP. (2002). Blood, 99, 3472-3475.
5. Buchdunger E, Matter A and Druker BJ. (2001). Biochim. Biophys. Acta, 1551, M11-18.
6. Carroll M, Ohno-Jones S, Tamura S, Buchdunger E, Zimmermann J, Lydon NB, Gilliland DG and Druker BJ. (1997). Blood, 90, 4947-4952.
7. Casnellie JE. (1991). Adv. Pharmacol., 22, 167-205.
8. Chang C-J and Geahlen RL. (1992). J. Natural Products, 55, 1529-1560.
9. Corbin AS, Buchdunger E, Pascal F and Druker BJ. (2002). J. Biol. Chem., 277, 32214-32219.
10. Corbin AS, Toledo LM, Lydon NB, Buchdunger E, Kuriyan J and Druker BJ. (2000). Blood, 96, 470a.
11. Deininger MW, Goldman JM, Lydon N and Melo JV. (1997). Blood, 90, 3691-3698.
12. Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, Heinrich MC, Tuveson DA, Singer S, Janicek M, Fletcher JA, Silverman SG, Silberman SL, Capdeville R, Kiese B, Peng B, Dimitrijevic S, Druker BJ, Corless C, Fletcher CD and Joensuu H. (2002). N. Engl. J. Med., 347, 472-480.
13. Dolci S, Williams DE, Ernst MK, Resnick JL, Brannan CI, Lock LF, Lyman SD, Boswell HS and Donovan PJ. (1991). Nat. Genetics, 352, 809-811.
14. Dorsey JF, Jove R, Kraker AJ and Wu J. (2000). Cancer Res., 60, 3127-3131.
15. Druker BJ and for the IRIS (International Randomized IFN vs STI571) Study Group. (2002). Proc. Am. Soc. Clin. Onc., 21, 1a.
16. Druker BJ and Lydon NB. (2000). J. Clin. Invest., 105, 3-7.
17. Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Fernandes Reese S, Ford JM, Capdeville R and Talpaz M. (2001a). N. Engl. J. Med., 344, 1038-1042.
18. Druker BJ, Talpaz M, Resta D, Peng B, Buchdunger E, Ford JM, Lydon NB, Kantarjian H, Capdeville R, Ohno-Jones S and Sawyers CL. (2001b). N. Engl. J. Med., 344, 1031-1037.
19. Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, Zimmermann J and Lydon NB. (1996). Nature Med., 2, 561-566.
20. Gambacorti-Passerini C, le Coutre P, Mologni L, Fanelli M, Bertazzoli C, Marchesi E, Di Nicola M, Biondi A, Corneo GM, Belotti D, Pogliani E and Lydon NB. (1997). Blood Cells Mol. Dis., 23, 380-394.
21. Gorre ME, Mohammed M, Ellwood K, Hsu N, Paquette R, Rao PN and Sawyers CL. (2001). Science, 293, 876-880.
22. Graham SM, Jorgensen HG, Allan E, Pearson C, Alcorn MJ, Richmond L and Holyoake TL. (2002). Blood, 99, 319-325.
23. Hochhaus A, Kreil S, Corbin AS, La Rosée P, Müller MC, Lahaye T, Hanfstein B, Schoch C, Cross NCP, Berger U, Gschaidmeier H, Druker BJ and Hehlmann R. (2002). Leukemia in press.
24. Hofmann WK, Jones LC, Lemp NA, de Vos S, Gschaidmeier H, Hoelzer D, Ottmann OG and Koeffler HP. (2001). Blood, 99, 1860-1862.
25. Holtz MS, Slovak ML, Zhang F, Sawyers CL, Forman SJ and Bhatia R. (2002). Blood, 99, 3792-3800.
26. Honma Y, Okabe KJ, Hozumi M, Uehara Y and Mizuno S. (1989). Cancer Res., 49, 331-334.
27. Honma Y, Okabe-Kado J, Kasukabe T, Hozumi M and Umezawa K. (1990). Japanese J. Cancer Res., 81, 1132-1136.
28. Hoover RR, Mahon FX, Melo JV and Daley GQ. (2002). Blood, 100, 1068-1071.
29. Kantarjian H, Sawyers C, Hochhaus A, Guilhot F, Schiffer C, Gambacorti-Passerini C, Niederwieser D, Resta D, Capdeville R, Zoellner U, Talpaz M and Druker B. (2002). New Engl. J. Med., 346, 645-652.
30. Kasper B, Fruehauf S, Schiedlmeier B, Buchdunger E, Ho AD and Zeller WJ. (1999). Cancer Chemother. Pharmacol., 44, 433-438.
31. Kaur G, Gazit A, Levitzki A, Stowe E, Cooney DA and Sausville EA. (1994). Anti-Cancer Drugs, 5, 213-222.
32. Kawada M, Tawara J, Tsuji T, Honma Y, Hozumi M, Wang JY and Umezawa K. (1993). Drugs Under Exp. and Clin. Res., 19, 235-241.
33. La Rosee P, Johnson K, O'Dwyer ME and Druker BJ. (2002). Exp. Hematol., 30, 729-737.
34. le Coutre P, Mologni L, Cleris L, Marchesi E, Buchdunger E, Giardini R, Formelli F and Gambacorti-Passerini C. (1999). J. Natl. Cancer Inst., 91, 163-168.
35. Lugo TG, Pendergast AM, Muller AJ and Witte ON. (1990). Science, 247, 1079-1082.
36. Marley SB, Deininger MW, Davidson RJ, Goldman JM and Gordon MY. (2000). Exp. Hematol., 28, 551-557.
37. Mow BM, Chandra J, Svingen PA, Hallgren CG, Weisberg E, Kottke TJ, Narayanan VL, Litzow MR, Griffin JD, Sausville EA, Tefferi A and Kaufmann SH. (2002). Blood, 99, 664-671.
38. Nichols GL, Raines MA, Vera JC, Lacomis L, Tempst P and Golde DW. (1994). Blood, 84, 2912-2918.
39. Oda T, Heaney C, Hagopian J, Okuda K, Griffin JD and Druker BJ. (1994). J. Biol. Chem., 269, 22925-22928.
40. Okuda K, Weisberg E, Gilliland DG and Griffin JD. (2001). Blood, 97, 2440-2448.
41. Ottmann OG, Druker BJ, Sawyers CL, Goldman JM, Reiffers J, Silver RT, Tura S, Fischer T, Deininger MW, Schiffer CA, Baccarani M, Gratwohl A, Hochhaus A, Hoelzer D, Fernandes-Reese S, Gathmann I, Capdeville R and O'Brien S. (2002). Blood, 100, 1965-1971.
42. Peng B, Hayes M, Racine-Poon A, Druker BJ, Talpaz M, Sawyers CL, Resta D, Ford JM, Lloyd P and Capdeville R. (2001). Proc. Am. Soc. Clin. Oncol., 20, 280a.
43. Porosnicu M, Nimmanapalli R, Nguyen D, Worthington E, Perkins C and Bhalla KN. (2001). Leukemia, 15, 772-778.
44. Roche-Lestienne C, Soenen-Cornu V, Grardel-Duflos N, Lai JL, Philippe N, Facon T, Fenaux P and Preudhomme C. (2002). Blood, 100, 1014-1018.
45. Russell ES. (1979). Adv. Genet., 20, 357-359.
46. Sawyers CL, Hochhaus A, Feldman E, Goldman JM, Miller CB, Ottmann OG, Schiffer CA, Talpaz M, Guilhot F, Deininger MWN, Fischer T, O'Brien SG, Stone RM, Gambacorti-Passerini CB, Russell NH, Reiffers JJ, Shea TC, Chapuis B, Coutre S, Tura S, Morra E, Larson RA, Saven A, Peschel C, Gratwohl A, Mandelli F, Ben-Am M, Gathmann I, Capdeville R, Paquette RL and Druker BJ. (2002). Blood, 99, 3530-3539.
47. Schindler T, Bornmann W, Pellicena P, Miller WT, Clarkson B and Kuriyan J. (2000). Science, 289, 1938-1942.
48. Schwartzberg PL, Stall AM, Hardin JD, Bowdish KS, Humaran T, Boast S, Harbison ML, Robertson EJ and Goff SP. (1991). Cell, 65, 1165-1175.
49. Senechal K, Heaney C, Druker B and Sawyers C. (1998). Mol. Cell. Biol., 18, 5082-5090.
50. Shah NP, Nicoll JM, Nagar B, Gorre ME, Paquette RL, Kuriyan J and Sawyers CL. (2002). Cancer Cell, 2, 117-125.
51. Soriano P. (1994). Genes Dev., 8, 1888-1896.
52. Soriano P. (1997). Development, 124, 2691-2700.
53. Sun X, Layton JE, Elefanty A and Lieschke GJ. (2001). Blood, 97, 2008-2015.
54. Talpaz M, Silver RT, Druker BJ, Goldman JM, Gambacorti-Passerini C, Guilhot F, Schiffer CA, Fischer T, Deininger MWN, Lennard AL, Hochhaus A, Ottmann OG, Gratwohl A, Baccarani M, Stone R, Tura S, Mahon F-X, Fernandes-Reese S, Gathmann I, Capdeville R, Kantarjian HM and Sawyers CL. (2002). Blood, 99, 1928-1937.
55. ten Hoeve J, Arlinghaus RB, Guo JQ and Heisterkamp N. (1994). Blood, 84, 1731-1736.
56. Topaly J, Schad M, Zeller WJ, Ho AD and Fruehauf S. (2001). Blood, 98, 617a.
57. Tybulewicz VL, Crawford CE, Jackson PK, Bronson RT and Mulligan RC, (1991). Cell, 65, 1153-1163.
58. von Bubnoff N, Schneller F, Peschel C and Duyster J. (2002). Lancet, 359, 487-491.
59. Yaish P, Gazit A, Gilon C and Levitzki A. (1988). Science, 242, 933-935.